Evaluation of Upper Anterior Teeth Retraction Rate Assisted by Two Corticotomy Techniques

Sponsor
Damascus University (Other)
Overall Status
Completed
CT.gov ID
NCT04847492
Collaborator
(none)
40
1
2
16.2
2.5

Study Details

Study Description

Brief Summary

This study aims to assess the dental changes, periodontal health and the pulp vitality in mini-screw supported en-masse retraction associated with traditional or flapless corticotomy techniques.

40 adult patients exhibiting class II division 1 malocclusion requiring upper first premolar extractions followed by en-masse retraction will participate in the study. They will be randomly and equally distributed into two groups: traditional corticotomy (20 patients) versus flapless corticotomy (20 patients). The corticotomy procedure will be performed pre-retraction. The dental changes will be assessed using dental casts. The impressions will be taken after finishing the leveling and alignment phase and before starting the en-masse retraction (T0), 1 month (T1), 2 months (T2), 3 months (T3), 4 months (T4), and 5 months (T5) following the onset of en-masse retraction. The final impression will be considered at the end of the en-masse retraction (when the canines reach Class Ι relationship).

Condition or Disease Intervention/Treatment Phase
  • Procedure: Traditional corticotomy
  • Procedure: Flapless corticotomy
N/A

Detailed Description

One of the most important challenges in daily practice is prolonged orthodontic treatment duration. For that lots of therapeutic procedures have been introduced to minimize orthodontic treatment time such as surgical interventions. Even though the traditional corticotomy with flap elevation proved to be effective in accelerating different types of tooth movement, it has been deemed aggressive. Therefore, minimally invasive surgical techniques have been proposed and labeled 'flapless corticotomies'.

In flapless corticotomy group, vertical soft-tissue incisions will be made on the buccal and palatal gingiva by using a blade N.15. One incision will be made between the roots of the six upper anterior teeth, and two incisions will be made between the upper canines and second premolars. The incisions will be 5 mm long and started 4 mm apical to the interdental papilla. Then a piezosurgery knife will be inserted to perform the cortical alveolar incisions with 3-mm in-depth and 8-mm in length. No suturing will be needed.

In traditional corticotomy group, a full-thickness mucoperiosteal flap will be elevated including the interdental papilla, and extended from the distal side of the second premolar on the right side to the same position on the left side without performing any vertical releasing incisions. The full-thickness flap will be extended 3 mm above the root apices, from the buccal and palatal sides, knowing that the incision in the incisal papilla region will be done around it with a (V) or (U) shape. Then, one vertical incision between the roots of upper anterior teeth and two vertical incisions in the site of first premolar extraction will be made by the piezosurgery knife. The vertical incisions will be connected by a horizontal incision using the piezosurgery knives. The vertical incisions will be 3 mm in depth, starting 2-3 mm apical to the alveolar crest, and extending 3 mm beyond the root apices. The interrupted technique of suturing will be done using a non-absorbent 3-0 black silk.

The en-masse retraction will be begun 4 days after carrying out the corticotomy procedure using 0.019×0.025-inch SS archwires with 8-10-mm long soldered hooks located distal to the lateral incisors. NiTi closed coil springs with 9-mm long will be extended from the mini-screws to the soldered hooks and applied 250-g of force per side. The patients' follow-up appointments will be every 2 weeks. The force will be measured on every appointment and adjusted if needed. The endpoint of the monitoring period will be the session when canines reached a class Ι relationship.

Study Design

Study Type:
Interventional
Actual Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Evaluation of Maxillary En-masse Retraction Rate Supported by Mini-screws and Assisted by Traditional or Flapless Corticotomy Techniques: A Randomized Controlled Trial
Actual Study Start Date :
Jun 9, 2017
Actual Primary Completion Date :
Jan 1, 2018
Actual Study Completion Date :
Oct 15, 2018

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Traditional corticotomy

Adult patients will be treated by en-masse retraction associated with traditional corticotomy.

Procedure: Traditional corticotomy
A full-thickness mucoperiosteal flap will be elevated including the interdental papilla, and extended from the distal side of the second premolar on the right side to the same position on the left side without performing any vertical releasing incisions. Then, one vertical incision between the roots of upper anterior teeth and two vertical incisions in the site of first premolar extraction will be made by the piezosurgery knife.

Experimental: Flapless corticotomy

Adult patients will be treated by en-masse retraction associated with flapless corticotomy.

Procedure: Flapless corticotomy
Vertical soft-tissue incisions will be made on the buccal and palatal gingiva by using a blade N.15. One incision will be made between the roots of the six upper anterior teeth, and two incisions will be made between the upper canines and the second premolars.

Outcome Measures

Primary Outcome Measures

  1. The rate of en-masse retraction of upper anterior teeth. [The calculation of the rate of retraction will be done once the retraction procedures finish. It is expected to happen within 5 months]

    The rate of en-masse retraction of upper anterior teeth (mm/month) in each group will be calculated. This outcome will be measured by the following steps: Drawing a projection from the upper canine apex to the middle palatal bone line. Drawing a projection from the upper central incisor edge to the middle palatal bone line. Drawing a projection from the mesial ending of the third palatal rugae to the middle palatal bone line. Measuring the distance (mm) between the canine apex and third palatal rugae projections. Measuring the distance (mm) between the central incisor edge and third palatal rugae projections. The rate of en-masse retraction will be measured by dividing the distance between the canine apex/central incisor edge projections and the third palatal rugae projection by the time elapsed between assessment times.

  2. Change in the anteroposterior movement of the molar at 5 months [T0:1 day before the beginning of the retraction phase. T1: after 1 month of the beginning of retraction phase . T2: after 2 months. T3: after 3 months. T4: after 4 months. T5: immediately after the end of retraction phase (expected to be after 5 months)]

    The anteroposterior movement of the molar (mm/month) in each group will be calculated. This outcome will be measured on the dental casts by drawing two projections from the central groove of the first maxillary molar and the mesial ending of the third palatal rugae to the middle palatal bone line. The anteroposterior movement of the first maxillary molar (mm) will be measured by dividing the distance between the two projections by the time elapsed between assessment times.

  3. Change in the inter-canine width at 5 months [T0:1 day before the beginning of the retraction phase. T1: after 1 month of the beginning of retraction phase . T2: after 2 months. T3: after 3 months. T4: after 4 months. T5: immediately after the end of retraction phase (expected to be after 5 months)]

    The change in the inter-canine width (mm/month) in each group will be calculated. Assessment will be performed by measuring the distance between the cusp tips of the two upper canines. This variable will be measured on dental casts.

  4. Change in the inter-molar width at 5 months [T0:1 day before the beginning of the retraction phase. T1: after 1 month of the beginning of retraction phase . T2: after 2 months. T3: after 3 months. T4: after 4 months. T5: immediately after the end of retraction phase (expected to be after 5 months)]

    The change in the inter-molar width (mm/month) in each group will be calculated. Assessment will be performed by measuring the distance between the the central groove of the two first maxillary molars. This variable will be measured on dental casts.

Secondary Outcome Measures

  1. The change in dental plaque index according to Silness and Loe [T0: immediately before the start of treatment; T1: one day before the commencement of the retraction phase; T2: immediately after the end of retraction phase (expected to be after 5 months)]

    Assessment will be performed using a gingival probe. (0) = No plaque. = A film of plaque adhering to the free gingival margin and adjacent area of the tooth. The plaque may be seen in situ only after application of disclosing solution or by using the probe on the tooth surface. = Moderate accumulation of soft deposits within the gingival pocket, or on the tooth and gingival margin which can be seen with the naked eye. = Abundance of soft matter within the gingival pocket and/or on the tooth and gingival margin.

  2. The change in gingival index according to Silness and Loe [T0: immediately before the start of treatment; T1: one day before the commencement of the retraction phase; T2: immediately after the end of retraction phase (expected to be after 5 months)]

    Assessment will be performed using a gingival probe. (0) = Normal gingiva. = Mild inflammation: slight change in color, slight oedema. No bleeding on probing. = Moderate inflammation: redness, oedema and glazing. Bleeding on probing. = Sever inflammation: marked redness and oedema, ulceration, and tendency to spontaneous bleeding

  3. The change in papillary bleeding index according to Muhlemann [T0: immediately before the start of treatment; T1: one day before the commencement of the retraction phase; T2: immediately after the end of retraction phase (expected to be after 5 months)]

    Assessment will be performed using a gingival probe. (0) = No bleeding. = A single discreet bleeding point appears. = Several isolated bleeding points or a single fine line of blood appears. = The interdental triangle fills with blood shortly after probing. = Profuse bleeding occurs after probing; blood flows immediately into the marginal sulcus.

  4. The change in gingival recession index according to Miller [T0: immediately before the start of treatment; T1: one day before the commencement of the retraction phase; T2: immediately after the end of retraction phase (expected to be after 5 months)]

    The presence of gingival recession on the studied teeth was determined by using a gingival probe and naked eye view, with direct clinical measurement from the cemento-enamel junction to the edge of the free gingiva in the event of the recession.

  5. Tooth vitality [T0: immediately before the start of treatment; T1: one day before the commencement of the retraction phase; T2: immediately after the end of retraction phase (expected to be after 5 months)]

    Assessment will be performed from the maxillary right first molar to the maxillary left first molar by using Ethyl chloride spray (endo ice) at a temperature -50°. Each tooth will be subjected to this ice and the resultant outcome is dichotomous (the tooth is vital, the tooth is not vital).

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 30 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Age range between 18 and 30 years.

  2. Class II division 1 malocclusion requiring extraction of upper first premolars.

  3. Mild to moderate skeletal class II malocclusion.

  4. Normal or excessive anterior facial height.

  5. No or mild crowding (tooth-size arch-length discrepancy ≤3 mm).

  6. Overjet >5 mm and <10 mm.

  7. Completion permanent dentition (regardless of third molars).

  8. No previous orthodontic treatment.

  9. No drug use or systematic disease that would affect the bone and tooth movement rate.

  10. Healthy periodontium and good oral hygiene.

Exclusion Criteria:
  1. Patients with previous orthodontic treatment.

  2. Patients with severe skeletal dysplasia in all three dimensions.

  3. Patients suffer from systemic diseases or syndromes

  4. Patients on medication for systemic disorders, pregnancy or steroid therapy.

  5. Patients showing any signs of active periodontal disease

  6. Patients with severe crowding (≥ 3.5 mm) in maxillary arch

  7. Patients with missing or extracted teeth in maxillary arch except third molar.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department of Orthodontics, University of Damascus Dental School Damascus Syrian Arab Republic

Sponsors and Collaborators

  • Damascus University

Investigators

  • Principal Investigator: Hanin Nizar Khlef, DDS,MSc, Specialist and Clinical Lecturer, Department of Orthodontics, University of Damascus
  • Study Chair: Mohammad Y Hajeer, DDS,MSc,PhD, Associate Professor of Orthodontics, University of Damascus Dental School, Damascus, Syria
  • Study Director: Omar Heshmeh, DDS,MSc,PhD, Professor of Oral and Maxillofacial Surgery, University of Damascus Dental School, Damascus, Syria

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Damascus University
ClinicalTrials.gov Identifier:
NCT04847492
Other Study ID Numbers:
  • UDDS-Ortho-03-2021
First Posted:
Apr 19, 2021
Last Update Posted:
Apr 21, 2021
Last Verified:
Apr 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Damascus University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 21, 2021